Abasic study for cell based gene therapy for dental implant

牙种植体细胞基因治疗的基础研究

基本信息

  • 批准号:
    18592157
  • 负责人:
  • 金额:
    $ 2.21万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2006
  • 资助国家:
    日本
  • 起止时间:
    2006 至 2007
  • 项目状态:
    已结题

项目摘要

Dental implant therapy has been proven as a predictable treatment method for replacement of missing teeth Nevertheless, the long healing period to make integration between bone and titanium after insertion of implants into the alveolar ridge may be one of a remaining problem. Gene therapy to accelerate on bone-implant integration might be a one of a new strategy to resolve the problem. We tested transfection efficiency and cytotoxicity of a plasmid DNA-nonviral vector complex including the code of beta-galactosidase reporter gene using lipofection, sonoporation and combination of these methods. Primaly bone marrow cells attached on cell culture plate surface were used for these experiments. The conditions of ultrasound power and duration were also tested for the sonoporation method.Lipofedion and sonoporation methods showed better transfection efficiencies than the control group. Cytotoxicity was higher with concentration of the reagents of liposome-DNA complex. Low cytotoxidty was shown on sonoporation with micro bubble equal to the control group. When the combination method of lipofection and sonoporation was used, deposition of the reagents was detected. It was suggested that optimal condition may exist on the ultrasound intensity and duration, which be correspondenced on the optimal plasmid-DNA concentration. Cell viability and transfection efficiency became worse when the condition was bad.
牙种植体治疗已被证明是一种可预测的修复缺失牙齿的治疗方法,然而,在将种植体植入牙槽骨脊后,骨与钛之间的漫长愈合时间可能是遗留问题之一。基因治疗加速种植体-骨整合可能是解决这一问题的新策略之一。我们用脂质体转染法、超声转染法和这三种方法相结合的方法检测了含有β-半乳糖苷酶报告基因编码的质粒DNA-非病毒载体复合体的转染率和细胞毒性。实验采用贴壁于细胞培养板表面的原代骨髓细胞。对超声功率和超声持续时间的条件进行了测试,结果表明,脂质体法和声孔法的转染率均高于对照组。随着脂质体-DNA复合体试剂浓度的增加,细胞毒作用增强。超声微泡显示细胞毒性较低,与对照组相当。采用脂质体介导法和超声造影法相结合,可检测到试剂的沉积。结果表明,超声强度和超声时间可能存在最佳条件,这与最适的质粒-DNA浓度相对应。当条件较差时,细胞存活率和转染率变差。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Low-Intensity Ultrasound Accelerates Differentiation of Osteoblasts on Acid-Etched Titanium Surface
低强度超声波加速酸蚀钛表面成骨细胞的分化
ラット骨髄由来の骨芽細胞様細胞への低出力超音波パルスの影響
低功率超声脉冲对大鼠骨髓来源的成骨细胞样细胞的影响
Effects of Low-intersity Pulsed Ultrasound on Osteoblastic Cells Deraived from Rat Bone Marrow Cells.
低强度脉冲超声对大鼠骨髓细胞来源的成骨细胞的影响。
Low-Intensity Pulsed Ultrasound Accelerates Differentiation of Osteoblasts on Titanium Surface
低强度脉冲超声波加速钛表面成骨细胞的分化
低出力超音波パルスがチタン上で培養した骨芽細胞様細胞に及ぼす影響
低功率超声脉冲对钛上培养的成骨细胞样细胞的影响
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    竹内 一夫;城所 貴;鈴木 龍;村上 弘;服部 正巳
  • 通讯作者:
    服部 正巳
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MASAMI Hattori其他文献

MASAMI Hattori的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

ICF: A novel dual-target gene therapy for safe and efficacious treatment of chronic non-infectious uveitis
ICF:一种安全有效治疗慢性非感染性葡萄膜炎的新型双靶点基因疗法
  • 批准号:
    MR/Z50385X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.21万
  • 项目类别:
    Research Grant
Longitudinal structural and cognitive functional imaging and outcome prediction in focal epilepsy treated with gene therapy and surgical resection.
基因治疗和手术切除治疗局灶性癫痫的纵向结构和认知功能成像及结果预测。
  • 批准号:
    MR/X031039/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.21万
  • 项目类别:
    Research Grant
Next-generation automation and PAT implementation for QbD and enhanced approaches for cell and gene therapy
QbD 的下一代自动化和 PAT 实施以及细胞和基因治疗的增强方法
  • 批准号:
    10087446
  • 财政年份:
    2024
  • 资助金额:
    $ 2.21万
  • 项目类别:
    Collaborative R&D
Phase I/II clinical trial of autologous T cell gene therapy to treat X-linked lymphoproliferative disease (XLP)
自体T细胞基因疗法治疗X连锁淋巴增殖性疾病(XLP)的I/II期临床试验
  • 批准号:
    MR/Y019458/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.21万
  • 项目类别:
    Research Grant
GeneT: The Gene Therapy CoE at the Center of Portugal
GeneT:葡萄牙中心的基因治疗 CoE
  • 批准号:
    10090933
  • 财政年份:
    2024
  • 资助金额:
    $ 2.21万
  • 项目类别:
    EU-Funded
Developing a gene therapy product to treat pressure ulcers in lower-limb amputees
开发一种基因治疗产品来治疗下肢截肢者的压力性溃疡
  • 批准号:
    2888189
  • 财政年份:
    2023
  • 资助金额:
    $ 2.21万
  • 项目类别:
    Studentship
Activation of long non-coding RNA by a gene therapy CRISPR/Cas9 approach to prevent vein graft failure
通过基因治疗 CRISPR/Cas9 方法激活长非编码 RNA 以预防静脉移植失败
  • 批准号:
    EP/X024563/1
  • 财政年份:
    2023
  • 资助金额:
    $ 2.21万
  • 项目类别:
    Research Grant
SBIR Phase I: Development of an Adjustable Gene Therapy Platform Technology
SBIR 第一阶段:可调节基因治疗平台技术的开发
  • 批准号:
    2240683
  • 财政年份:
    2023
  • 资助金额:
    $ 2.21万
  • 项目类别:
    Standard Grant
Exploration novel effects of SHED-TK-derived exosomes on TK/GCV suicide gene therapy
探索SHED-TK衍生的外泌体对TK/GCV自杀基因治疗的新作用
  • 批准号:
    23K15643
  • 财政年份:
    2023
  • 资助金额:
    $ 2.21万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Gene expression profiling of skin ulcers for short-acting in vivo gene therapy
皮肤溃疡的基因表达谱用于短效体内基因治疗
  • 批准号:
    23K19673
  • 财政年份:
    2023
  • 资助金额:
    $ 2.21万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了